封面
市場調查報告書
商品編碼
1538468

幹細胞研究抗體市場報告:2030 年趨勢、預測與競爭分析

Stem Cell Research Antibody Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

幹細胞研究抗體的趨勢和預測

2024年至2030年,全球幹細胞研究抗體市場預計將以5.2%的複合年成長率成長。該市場的主要驅動力是對幹細胞研究日益成長的興趣和投資、單株抗體生產、重組抗體生產和高通量篩檢方法等抗體生產技術的持續進步,以及政府的資助舉措和支持。津貼進行幹細胞研究計劃。全球幹細胞研究抗體市場的未來前景廣闊,製藥和生物技術、CRO 和 CDMO 以及學術和研究機構市場充滿機會。

分段幹細胞研究抗體

該研究包括按類型、應用和地區分類的全球幹細胞研究抗體的預測。

幹細胞研究抗體市場洞察

Lucintel 表示,預計神經元在預測期內將經歷最高的成長。

在這個市場中,藥品和生物技術預計將經歷最高的成長。

預計北美地區在預測期內將出現最高的成長。

常問問題

Q1.市場成長預測是多少:

A1. 2024年至2030年,全球幹細胞研究抗體市場預計將以5.2%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是:

A2. 該市場的主要驅動力是對幹細胞研究的興趣和投資的增加,單株抗體生產、重組抗體生產和高通量篩檢方法等抗體生產技術的持續進步,以及政府的資助舉措和對幹細胞的津貼。

Q3.市場的主要細分市場是:

A3. 全球幹細胞研究抗體市場的未來對於製藥和生物技術公司、CRO和CDMO以及學術和研究機構市場來說是充滿希望的。

Q4.市場的主要企業是:

A4. 生產幹細胞研究抗體的主要企業如下:

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals

Q5.未來最大的細分市場是什麼?

A5.Lucintel 預測神經元在預測期內將經歷最高的成長。

Q6.未來五年預計哪些地區的市場成長最大?

A6. 預計北美地區在預測期內將出現最高成長。

Q7. 可以客製化報告嗎?

A7。

目錄

第1章執行摘要

第2章全球幹細胞研究抗體市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球幹細胞研究抗體市場趨勢(2018-2023)與預測(2024-2030)
  • 全球幹細胞研究抗體市場(按類型)
    • 神經細胞
    • 造血細胞
    • 間質細胞
    • 內皮細胞
  • 全球幹細胞研究抗體市場(依應用)
    • 製藥和生物技術公司
    • CRO,CDMO
    • 學術/研究機構
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球幹細胞研究抗體市場
  • 北美幹細胞研究抗體市場
  • 歐洲幹細胞研究抗體市場
  • 亞太地區幹細胞研究抗體市場
  • 其他區域幹細胞研究抗體市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球幹細胞研究抗體市場的成長機會(按類型)
    • 全球幹細胞研究抗體市場應用的成長機會
    • 全球幹細胞研究抗體市場成長機會(按地區)
  • 全球幹細胞研究抗體市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球幹細胞研究抗體市場產能
    • 全球幹細胞研究抗體市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals
簡介目錄

Stem Cell Research Antibody Trends and Forecast

The future of the global stem cell research antibody market looks promising with opportunities in the pharmaceutical & biotechnology company, CRO & CDMO, and academic & research institute markets. The global stem cell research antibody market is expected to grow with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are increasing interest and investment in stem cell research, ongoing advancements in antibody production technologies, such as monoclonal antibody production, recombinant antibody engineering, and high-throughput screening methods, as well as, government funding initiatives and research grants support stem cell research projects.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Stem Cell Research Antibody by Segment

The study includes a forecast for the global stem cell research antibody by type, application, and region.

Stem Cell Research Antibody Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Neural
  • Hematopoietic
  • Mesenchymal
  • Endothelial

Stem Cell Research Antibody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • CRO & CDMO
  • Academic & Research Institutes
  • Others

Stem Cell Research Antibody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stem Cell Research Antibody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stem cell research antibody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell research antibody companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals

Stem Cell Research Antibody Market Insights

Lucintel forecasts that neural is expected to witness the highest growth over the forecast period.

Within this market, pharmaceutical & biotechnology is expected to witness the highest growth.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Stem Cell Research Antibody Market

Market Size Estimates: Stem cell research antibody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stem cell research antibody market size by type, application, and region in terms of value ($B).

Regional Analysis: Stem cell research antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the stem cell research antibody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stem cell research antibody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for stem cell research antibody market?

Answer: The global stem cell research antibody market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the stem cell research antibody market?

Answer: The major drivers for this market are increasing interest and investment in stem cell research, ongoing advancements in antibody production technologies, such as monoclonal antibody production, recombinant antibody engineering, and high-throughput screening methods, as well as, government funding initiatives and research grants support stem cell research projects.

Q3. What are the major segments for stem cell research antibody market?

Answer: The future of the global stem cell research antibody market looks promising with opportunities in the pharmaceutical & biotechnology company, CRO & CDMO, and academic & research institute markets.

Q4. Who are the key stem cell research antibody market companies?

Answer: Some of the key stem cell research antibody companies are as follows:

  • Thermo Fisher Scientific
  • Merck
  • Abcam
  • Cell Signaling Technology
  • R&D Systems
  • BD Biosciences
  • BioLegend
  • Bio-Rad Antibodies
  • GeneTex
  • Novus Biologicals

Q5. Which stem cell research antibody market segment will be the largest in future?

Answer: Lucintel forecasts that neural is expected to witness the highest growth over the forecast period.

Q6. In stem cell research antibody market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stem cell research antibody market by type (neural, hematopoietic, mesenchymal, and endothelial), application (pharmaceutical & biotechnology companies, CRO & CDMO, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stem Cell Research Antibody Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stem Cell Research Antibody Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stem Cell Research Antibody Market by Type
    • 3.3.1: Neural
    • 3.3.2: Hematopoietic
    • 3.3.3: Mesenchymal
    • 3.3.4: Endothelial
  • 3.4: Global Stem Cell Research Antibody Market by Application
    • 3.4.1: Pharmaceutical & Biotechnology Companies
    • 3.4.2: CRO & CDMO
    • 3.4.3: Academic & Research Institutes
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stem Cell Research Antibody Market by Region
  • 4.2: North American Stem Cell Research Antibody Market
    • 4.2.1: North American Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.2.2: North American Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others
  • 4.3: European Stem Cell Research Antibody Market
    • 4.3.1: European Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.3.2: European Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others
  • 4.4: APAC Stem Cell Research Antibody Market
    • 4.4.1: APAC Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.4.2: APAC Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others
  • 4.5: ROW Stem Cell Research Antibody Market
    • 4.5.1: ROW Stem Cell Research Antibody Market by Type: Neural, Hematopoietic, Mesenchymal, and Endothelial
    • 4.5.2: ROW Stem Cell Research Antibody Market by Application: Pharmaceutical & Biotechnology Companies, CRO & CDMO, Academic & Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stem Cell Research Antibody Market by Type
    • 6.1.2: Growth Opportunities for the Global Stem Cell Research Antibody Market by Application
    • 6.1.3: Growth Opportunities for the Global Stem Cell Research Antibody Market by Region
  • 6.2: Emerging Trends in the Global Stem Cell Research Antibody Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stem Cell Research Antibody Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Research Antibody Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck
  • 7.3: Abcam
  • 7.4: Cell Signaling Technology
  • 7.5: R&D Systems
  • 7.6: BD Biosciences
  • 7.7: BioLegend
  • 7.8: Bio-Rad Antibodies
  • 7.9: GeneTex
  • 7.10: Novus Biologicals